MD, PhD candidate
University Hospitals Leuven, Belgium
Leuven, Vlaams-Brabant, Belgium
Dr. Matthias M Engelen is an M.D. Ph.D. candidate at the Center for Molecular and Vascular Biology (CMVB), University of Leuven, under the supervision of prof. dr. Thomas Vanassche and prof. dr. Peter Verhamme. He graduated as a medical doctor in 2017 and is now trained as a junior cardiologist at the University Hospitals Leuven. His research interests focus on thrombosis and hemostasis, but since the beginning of the COVID-19 pandemic, he has mainly focussed on clinical research investigating the thromboinflammatory aspects of COVID-19. During this period, he also collaborated on several other randomized controlled COVID-19 trials and worked intensively on the thrombosis and bleeding disorder unit in the University Hospitals Leuven.
OC 06.2 - Emicizumab for Acquired Hemophilia A - A Case Series
Saturday, June 24, 2023
13:15 – 13:30 ET